485 related articles for article (PubMed ID: 8735647)
1. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
Andersen HL; Kilpatrick IC
Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
[TBL] [Abstract][Full Text] [Related]
2. In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions.
Teismann P; Ferger B
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):337-48. PubMed ID: 10800755
[TBL] [Abstract][Full Text] [Related]
3. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
Haleem DJ; Shireen E; Haleem MA
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
[TBL] [Abstract][Full Text] [Related]
4. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
[TBL] [Abstract][Full Text] [Related]
5. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
6. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
[TBL] [Abstract][Full Text] [Related]
7. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress.
Saphier D; Welch JE
J Neurochem; 1995 Feb; 64(2):767-76. PubMed ID: 7530293
[TBL] [Abstract][Full Text] [Related]
8. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens.
Ohno Y; Shimizu S; Imaki J; Ishihara S; Sofue N; Sasa M; Kawai Y
Neuropharmacology; 2008 Oct; 55(5):717-23. PubMed ID: 18585397
[TBL] [Abstract][Full Text] [Related]
9. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
10. 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release.
Lucas G; Bonhomme N; De Deurwaerdère P; Le Moal M; Spampinato U
Psychopharmacology (Berl); 1997 May; 131(1):57-63. PubMed ID: 9181636
[TBL] [Abstract][Full Text] [Related]
11. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
12. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
Prinssen EP; Koek W; Colpaert FC; Kleven MS
Behav Pharmacol; 2000 Jun; 11(3-4):299-305. PubMed ID: 11103884
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Nader MA; Barrett JE
Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
[TBL] [Abstract][Full Text] [Related]
14. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis.
Invernizzi RW; Cervo L; Samanin R
Neuropharmacology; 1988 May; 27(5):515-8. PubMed ID: 2969083
[TBL] [Abstract][Full Text] [Related]
15. Single restraint stress sensitizes acute chewing movements induced by haloperidol, but not if the 5-HT1A agonist 8-OH-DPAT is given prior to stress.
Fdez Espejo E; Gil E
Brain Res; 1997 May; 755(2):351-5. PubMed ID: 9175906
[TBL] [Abstract][Full Text] [Related]
16. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
Tucci S; Fernandez R; Baptista T; Murzi E; Hernandez L
Brain Res Bull; 1994; 35(2):125-33. PubMed ID: 7953768
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor blockade in nucleus accumbens or caudate nucleus differentially affects feeding induced by 8-OH-DPAT injected into dorsal or median raphe.
Fletcher PJ
Brain Res; 1991 Jun; 552(2):181-9. PubMed ID: 1833034
[TBL] [Abstract][Full Text] [Related]
18. Enhancement by ipsapirone of dopamine release in the rat striatum.
Gołembiowska K; Wedzony K
Pol J Pharmacol; 1993; 45(3):299-308. PubMed ID: 7693136
[TBL] [Abstract][Full Text] [Related]
19. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
[TBL] [Abstract][Full Text] [Related]
20. 8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol.
Carey R; Damianopoulos E; De Palma G
Pharmacol Biochem Behav; 2000 Aug; 66(4):863-72. PubMed ID: 10973527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
